Loading organizations...
§ Private Profile · Nottingham, Nottingham, United Kingdom
A medical device company developing 4Degra, a proprietary 3D-printable biodegradable biomaterial for resorbable orthopaedic implants.
Based in Nottingham, United Kingdom, 4D Biomaterials is a medical device company that develops and manufactures 3D-printable, biodegradable polycarbonate resins for surgical implants. The company's proprietary material, 4Degra, can be printed into complex geometries ranging from flexible films to rigid orthopaedic structures that safely degrade within the body. Operating as a business-to-business materials supplier and co-developer, the firm has raised a total of £5 million in equity financing, including a £3.4 million Series A round. 4D Biomaterials is backed by venture capital investors such as Oshen Holdings, DSW Ventures, and Mercia Asset Management, and it maintains a strategic corporate partnership with Boston Micro Fabrication. The organization is currently preparing to seek FDA clearance to commercialize its bioresorbable devices within the United States orthopaedic market. The company was founded in 2020 as a joint university spin-out by Professor Andrew Dove and Professor Michael Shaver.
4D Biomaterials has raised $6.6M across 2 funding rounds.
4D Biomaterials has raised $6.6M in total across 2 funding rounds.
4D Biomaterials has raised $6.6M across 2 funding rounds. Most recently, it raised $4.4M Series A in July 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 25, 2024 | $4.4M Series A | Oshen Holdings | — | Announced |
| Jul 29, 2021 | $2.2M Venture Round | DSW Ventures | — | Announced |
4D Biomaterials has raised $6.6M in total across 2 funding rounds.
4D Biomaterials's investors include Oshen Holdings, DSW Ventures.